Pulmonary Metastases
14
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis
Study of Outcomes of Radiofrequency Ablation of Lung Tumors
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
A Randomised Trial of Pulmonary Metastasectomy in Colorectal Cancer
Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma
Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies
Use of Thoracoscopic Intraoperative Lung Ultrasound to Identify Pulmonary Metastases in Patients Submitted to Pulmonary Metastasectomy With Radical Intent.
Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)
Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation